Masimo Corporation (MASI)
| Market Cap | 15.68B |
| Revenue (ttm) | 1.18B |
| Net Income (ttm) | 223.69M |
| Shares Out | 55.03M |
| EPS (ttm) | 3.86 |
| PE Ratio | 73.94 |
| Forward PE | 68.03 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 348,496 |
| Open | 283.35 |
| Previous Close | 283.35 |
| Day's Range | 279.37 - 285.66 |
| 52-Week Range | 205.10 - 288.27 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 298.80 (+4.7%) |
| Est. Earnings Date | Oct 26, 2021 |
About MASI
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion ind...
Financial Performance
In 2020, Masimo's revenue was $1.14 billion, an increase of 21.96% compared to the previous year's $937.84 million. Earnings were $240.30 million, an increase of 22.47%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for Masimo stock is "Buy." The 12-month stock price forecast is 298.80, which is an increase of 4.67% from the latest price.
News
Masimo (MASI) Earnings Expected to Grow: Should You Buy?
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrason...
IRVINE, Calif.--(BUSINESS WIRE)--An abstract presented at ANESTHESIOLOGY 2021 recommended use of noninvasive, continuous Masimo PVi® to guide fluid administration during oncosurgery.
Masimo to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, October 26
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2021 financial results for the period ended October 2, 2021, after the market closes on Tuesday, October 26, 2021. The c...
Masimo's (MASI) EMMA Capnography on Neonates Favored by New Study
Masimo's (MASI) EMMA is likely to aid in maintaining an optimal range of PaCO2 in preterm infants undergoing mechanical ventilation in the neonatal intensive care unit.
New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates
TOKYO--(BUSINESS WIRE)--A new study found that the Masimo EMMA® Portable Capnograph "may be considered an effective monitoring device" for mechanically ventilated neonates.
Here's Why You Should Retain Masimo (MASI) Stock For Now
Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.
Masimo CEO Joe Kiani Appointed to President's Council of Advisors on Science and Technology
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Founder and CEO Joe Kiani has been appointed to President Biden's Council of Advisors on Science and Technology.
5 Good Companies With High Profitability
According to the “Good Companies Screen,” one of several Premium screens under the All-in-One Screener, five stocks with high financial strength and profitability are Edwards Lifesciences Corp. ( EW , F...
Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on
Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.
Masimo (MASI) Launches SuperSensor, Boosts Product Profile
Masimo's (MASI) launch of SuperSensor can help clinicians to continuously monitor patients through one comprehensive, convenient, noninvasive fingertip solution.
Masimo Launches Single-patient-use rainbow® SuperSensor™
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo announces the CE marking & European launch of the single-patient-use rainbow® SuperSensor™, with 12 noninvasive parameters on a single sensor.
Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, Septemb...
Masimo's (MASI) ORi Favored by New Study For ICU Patients' ETI
Masimo's (MASI) ORi is expected to provide early warnings of impending hypoxemia during the ETI procedure, thus aiding in averting any adverse incident.
Masimo (MASI) Ties Up to Educate on Prescription Opioid Overuse
Masimo (MASI) partners with Penington Institute to increase awareness on overdose from prescription opioids.
New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubatio...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found that use of Masimo ORi™ on ICU patients may facilitate "preventive action" against hypoxemia during endotracheal intubation.
Masimo Stock Will Likely Continue To Make Fresh Highs
The stock price of Masimo Corporation, a medical devices company best known for its remote patient monitoring systems, reached its all-time high of $287 just last week before a recent decline resulted i...
Masimo (MASI) Strengthens Global Footprint With New Launch
Masimo's (MASI) western Europe launch of SafetyNet Alert not only expands its global presence but also aids in protecting patients taking opioids at home.
Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose
LONDON--(BUSINESS WIRE)--Masimo is marking International Overdose Awareness Day by partnering with the Penington Institute to raise awareness of the risks of opioid overdose.
Masimo SafetyNet Alert™ Launches in Western Europe
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo SafetyNet Alert™, an oxygen saturation monitoring and alert system designed for use at home, has been launched in Western Europe.
Masimo (MASI) Up 6% Since Last Earnings Report: Can It Continue?
Masimo (MASI) reported earnings 30 days ago. What's next for the stock?
Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
IRVINE, Calif.--(BUSINESS WIRE)--Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
Here's Why You Should Retain Masimo (MASI) Stock For Now
Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.
Masimo's (MASI) Noninvasive Continuous PVi Favored by New Study
Masimo (MASI) reports study findings that will aid clinicians in getting meaningful information with respect to monitoring the volume status in critically ill patients with spontaneous breathing.
New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A study found a "strong correlation" between change in Masimo PVi® & volume of fluid removed during hemodialysis in spontaneously breathing patients.
Masimo (MASI) Bridge Hailed as Opioid Substitute in New Study
Masimo's (MASI) Bridge device is likely to allow more patients to be benefited by auriculotherapy, thereby reducing the possibility of opioid overuse.